MedTrace Logo

EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy

NCT06376682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-09-22

Study results available
· View outcomes & findings →

Summary

Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for bone percutaneous procedures.

Conditions

Interventions

PROCEDURE

CT-guided bone percutaneous procedure

The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures (thermal ablation, bone consolidation, biopsy procedures).

Sponsors & Collaborators

  • ICUREsearch

    collaborator INDUSTRY

  • Quantum Surgical

    lead INDUSTRY

Principal Investigators

  • Baptiste BONNET · Gustave Roussy Cancer Institute

  • Nicolas STACOFFE · Hospices Civils de Lyon

  • Gilles PIANA · Paoli-Calmettes Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2024-11-29
Completion
2025-01-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06376682 on ClinicalTrials.gov